1.

What Are The Implications Of The New Code For Manufacturers Of Radiopharmaceuticals?

Answer»

The IMPLICATIONS for radiopharmaceuticals manufacturers are similar to those for other medicines manufacturers. The GUIDE to INTERPRETATION of the 2002 Code for manufacturing the PET radiopharmaceutical Fludeoxyglucose [18F] Injection has been revised to REFLECT the 2009 Code.

The implications for radiopharmaceuticals manufacturers are similar to those for other medicines manufacturers. The Guide to interpretation of the 2002 Code for manufacturing the PET radiopharmaceutical Fludeoxyglucose [18F] Injection has been revised to reflect the 2009 Code.



Discussion

No Comment Found